Method development and validation of simultaneous estimation of acetaminophen and behydrocodone in tablet dosage forms

Authors

  • B.Bhanu Priya Department of Pharmaceutical Analysis, Malla Reddy Institute of Pharmaceutical Sciences, Maisammaguda, Dhullapally, Secunderabad-500014, Telangana State, India
  • R.V Valli Kumari Department of Pharmaceutical Analysis, Malla Reddy Institute of Pharmaceutical Sciences, Maisammaguda, Dhullapally, Secunderabad-500014, Telangana State, India
  • M.Satish Kumar Department of Pharmaceutical Analysis, Malla Reddy Institute of Pharmaceutical Sciences, Maisammaguda, Dhullapally, Secunderabad-500014, Telangana State, India

DOI:

https://doi.org/10.61096/ijpar.v8.iss4.2019.576-589

Keywords:

Acetaminophen, Benzhydrocodone, RP-HPLC.

Abstract

A RP-HPLC  procedure  is  developed,  validated  and  applied  for  simultaneous  estimation  of  acetaminophen  and  benzhydrocodone   in tablets. Procedure  is  based  on  separation  and  analysis  of  acetaminophen  and  benzhydrocodone in Hibar C18 column  and  0.1M  K2HPO4:  methanol  (65:35v\v)  mixture  as  stationary  and  mobile  phase,  respectively.  The  elution  time  values  for  acetaminophen  and  benzhydrocodone  were  3.692min  and  4.956  min,  respectively.  Linear  ranges  for  acetaminophen  and  benzhydrocodone  are  162.5-487.5 µg/ml  and  3.06-9.18 µg/ml,  respectively. The  values  of  sensitivity  were  0.311 µg/ml   (LOD)  and  1.035 µg/ml  (LOQ)  for acetaminophen  and  0.036  (LOD)  µg/ml  and  0.121 µg/ml  (LOQ)  for benzhydrocodone. The validation parameters are tested using guidelines of ICH. The validation values obtained are well acceptable. The  method  proved  as  suitable  procedure  for  assay  acetaminophen  and  benzhydrocodone  in  tablet  dosage  forms  with  good  assay  percent  values.

Downloads

Published

2022-09-27

How to Cite

B.Bhanu Priya, R.V Valli Kumari, & M.Satish Kumar. (2022). Method development and validation of simultaneous estimation of acetaminophen and behydrocodone in tablet dosage forms. IJPAR JOURNAL, 8(4), 576–589. https://doi.org/10.61096/ijpar.v8.iss4.2019.576-589